Biography & Research:
Dr. Ron Handels has obtained his PhD in 2014 on the potential of Alzheimer's disease biomarkers from a health-economic perspective. He continued to focus on health-economic evaluation of biomarkers, disease-modifying treatment and care interventions in in several European projects. He is specialized in cost-effectiveness analysis and operates from a network of health-economists across Europe.